Mirati Therapeutics
MRTX
#3422
Rank
โ‚ฌ3.75 B
Marketcap
53,51ย โ‚ฌ
Share price
0.00%
Change (1 day)
56.37%
Change (1 year)

EPS for Mirati Therapeutics (MRTX)

EPS in 2023 (TTM): -11,34ย โ‚ฌ

According to Mirati Therapeutics's latest financial reports the company's current EPS (TTM) is -11,14ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -12,01ย โ‚ฌ a decrease over its 2021 EPS that were of -10,18ย โ‚ฌ.

EPS history for Mirati Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-11,34ย โ‚ฌ-5.64%
2022-12,01ย โ‚ฌ17.99%
2021-10,18ย โ‚ฌ40.5%
2020-7,25ย โ‚ฌ40.96%
2019-5,14ย โ‚ฌ77.92%
2018-2,89ย โ‚ฌ13.62%
2017-2,54ย โ‚ฌ-33.57%
2016-3,83ย โ‚ฌ10.82%
2015-3,45ย โ‚ฌ16.98%
2014-2,95ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
TravelCenters of America
TA
8,68ย โ‚ฌ-177.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-0,05470ย โ‚ฌ-99.51% Bahamas